📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial. (2022)

First Author: Loeb M

Attributed to: A randomized controlled trial of influenza vaccine to prevent adverse vascular events. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00432-6

PubMed Identifier: 36400089

Publication URI: http://europepmc.org/abstract/MED/36400089

Type: Journal Article/Review

Volume: 10

Parent Publication: The Lancet. Global health

Issue: 12

ISSN: 2214-109X